Trial Profile
Activity of dalbavancin against comparator agents in patients with bacteremia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2018
Price :
$35
*
At a glance
- Drugs Dalbavancin (Primary) ; Daptomycin; Linezolid; Teicoplanin; Vancomycin
- Indications Bacterial infections
- Focus Therapeutic Use
- 08 Nov 2018 New trial record
- 07 Oct 2018 Results assessing anti microbial activity of Dalbavancin in patients hospitalised with bacteremia, presented at the IDWeek 2018.